ED Drug Labeling Revised For Potential Risk Of Hearing Loss
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA identifies 29 postmarketing reports of sudden hearing loss in patients using PDE 5 inhibitors, including Cialis, Levitra and Viagra.
You may also be interested in...
FDA Alters Levitra, Effexor XR Labels
Erectile-dysfunction package insert will now note phenomenon of sudden temporary memory loss.
FDA Alters Levitra, Effexor XR Labels
Erectile-dysfunction package insert will now note phenomenon of sudden temporary memory loss.
Viagra Non-Prescription Switch Would Face High Bar For Safety
Inappropriate selection, intentional or unintentional off-label use could exacerbate concerns like blindness, drug interactions, according to some experts.